[HTML][HTML] Cetuximab, docetaxel, and cisplatin as first-line treatment in patients with recurrent or metastatic head and neck squamous cell carcinoma: a multicenter …
J Guigay, J Fayette, AF Dillies, C Sire, JN Kerger… - Annals of …, 2015 - Elsevier
Background Cetuximab in combination with platinum and 5-fluorouracil is the standard of
care in the first-line treatment of patients with recurrent/metastatic head and neck squamous …
care in the first-line treatment of patients with recurrent/metastatic head and neck squamous …
Cetuximab, docetaxel, and cisplatin as first-line treatment in patients with recurrent or metastatic head and neck squamous cell carcinoma: a multicenter, phase II …
J Guigay, J Fayette, AF Dillies, C Sire… - Annals of oncology …, 2015 - pubmed.ncbi.nlm.nih.gov
Background Cetuximab in combination with platinum and 5-fluorouracil is the standard of
care in the first-line treatment of patients with recurrent/metastatic head and neck squamous …
care in the first-line treatment of patients with recurrent/metastatic head and neck squamous …
Cetuximab, docetaxel, and cisplatin as first-line treatment in patients with recurrent or metastatic head and neck squamous cell carcinoma: a multicenter, phase II …
J Guigay, J Fayette, AF Dillies, C Sire… - Annals of …, 2015 - annalsofoncology.org
Background Cetuximab in combination with platinum and 5-fluorouracil is the standard of
care in the first-line treatment of patients with recurrent/metastatic head and neck squamous …
care in the first-line treatment of patients with recurrent/metastatic head and neck squamous …
[PDF][PDF] Cetuximab, docetaxel, and cisplatin as first-line treatment in patients with recurrent or metastatic head and neck squamous cell carcinoma: a multicenter, phase …
J Guigay, J Fayette, AF Dillies, C Sire, JN Kerger… - Ann Oncol, 2011 - dial.uclouvain.be
Background: Cetuximab in combination with platinum and 5-fluorouracil is the standard of
care in the first-line treatment of patients with recurrent/metastatic head and neck squamous …
care in the first-line treatment of patients with recurrent/metastatic head and neck squamous …
[PDF][PDF] Cetuximab, docetaxel, and cisplatin as first-line treatment in patients with recurrent or metastatic head and neck squamous cell carcinoma: a multicenter, phase …
J Guigay, J Fayette, AF Dillies, C Sire, JN Kerger… - Ann Oncol, 2011 - researchgate.net
Background: Cetuximab in combination with platinum and 5-fluorouracil is the standard of
care in the first-line treatment of patients with recurrent/metastatic head and neck squamous …
care in the first-line treatment of patients with recurrent/metastatic head and neck squamous …
Cetuximab, docetaxel, and cisplatin as first-line treatment in patients with recurrent or metastatic head and neck squamous cell carcinoma: a multicenter, phase II …
J Guigay, J Fayette, AF Dillies, C Sire… - Annals of Oncology …, 2015 - europepmc.org
Background Cetuximab in combination with platinum and 5-fluorouracil is the standard of
care in the first-line treatment of patients with recurrent/metastatic head and neck squamous …
care in the first-line treatment of patients with recurrent/metastatic head and neck squamous …
[引用][C] Cetuximab, docetaxel, and cisplatin as first-line treatment in patients with recurrent or metastatic head and neck squamous cell carcinoma: a multicenter, phase …
J Guigay, J Fayette, AF Dillies, C Sire, JN Kerger… - Annals of …, 2015 - cir.nii.ac.jp
Cetuximab, docetaxel, and cisplatin as first-line treatment in patients with recurrent or metastatic
head and neck squamous cell carcinoma: a multicenter, phase II GORTEC study | CiNii …
head and neck squamous cell carcinoma: a multicenter, phase II GORTEC study | CiNii …
Cetuximab, docetaxel, and cisplatin as first-line treatment in patients with recurrent or metastatic head and neck squamous cell carcinoma: a multicenter, phase II …
J Guigay, J Fayette, AF Dillies, C Sire… - Annals of oncology …, 2015 - dial.uclouvain.be
Cetuximab in combination with platinum and 5-fluorouracil is the standard of care in the first-
line treatment of patients with recurrent/metastatic head and neck squamous cell carcinoma …
line treatment of patients with recurrent/metastatic head and neck squamous cell carcinoma …